The latest company updates, technical articles, and industry content.
Hydroxyapatite microsphere OEM projects depend on more than supply, especially when batch stability and validation requirements matter.
View Details
With compliant hydroxyapatite microsphere products entering the market, 2025 is shaping up to be a key year for material optimization, product iteration, and broader use in aesthetic medicine.
View Details
Radiesse's Class III registration certificate in China gives the market a clearer regulatory benchmark for calcium hydroxyapatite filler products.
View Details
China's first approval for an injectable calcium hydroxyapatite microsphere facial filler sets a meaningful regulatory benchmark for the domestic aesthetics market.
View Details
Nanjing Junzhuo resumes the new year with continued focus on biomaterial R&D, hydroxyapatite microspheres, and long-term customer value.
View Details
Nanjing Junzhuo thanks customers and partners for moving through 2024 together and highlights continued progress in biomaterial innovation, global development, and future cooperation.
View Details